Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2011

Kwak K, Yemelyanova A, Roden RB. Prevention of cancer by prophylactic human papillomavirus vaccines. Curr Opin Immunol. 2011;23(2):244-51.

Glezerman IG, M Pietanza C, Miller V, Seshan SV. Kidney tubular toxicity of maintenance pemetrexed therapy. Am J Kidney Dis. 2011;58(5):817-20.

Chen C, Chai J, Singh L, Kuo C-, Jin L, Feng T, et al. Characterization of an in vitro differentiation assay for pancreatic-like cell development from murine embryonic stem cells: detailed gene expression analysis. Assay Drug Dev Technol. 2011;9(4):403-19.

Lee SH, Jia S, Zhu Y, Utermark T, Signoretti S, Loda M, et al. Transgenic expression of polyomavirus middle T antigen in the mouse prostate gives rise to carcinoma. J Virol. 2011;85(11):5581-92.

Ling S, Chang X, Schultz L, Lee TK, Chaux A, Marchionni L, et al. An EGFR-ERK-SOX9 signaling cascade links urothelial development and regeneration to cancer. Cancer Res. 2011;71(11):3812-21.

Hundley AF, Magro C, Bartholomew D. Vaginal agglutination: chronic graft-versus-host disease mimics lichen planus. J Low Genit Tract Dis. 2011;15(1):71-4.

Flavin R, Zadra G, Loda M. Metabolic alterations and targeted therapies in prostate cancer. J Pathol. 2011;223(2):283-94.

Calloway N, Owens T, Corwith K, Rodgers W, Holowka D, Baird B. Stimulated association of STIM1 and Orai1 is regulated by the balance of PtdIns(4,5)P₂ between distinct membrane pools. J Cell Sci. 2011;124(Pt 15):2602-10.

Rink M, Chun FK, Robinson B, Sun M, Karakiewicz PI, Bensalah K, et al. Tissue-based molecular markers for renal cell carcinoma. Minerva Urol Nefrol. 2011;63(4):293-308.

Rosai J. Thymomas, committees, and memory lapses. Am J Clin Pathol. 2011;135(4):648; author reply 649.